Serial Number
98609776
Owner
Fresenius Kabi Deutschland GmbHAttorney
Scott D. WoldowFiling Date
Jun 20, 2024
Serial #98609776 Trademark
Serial Number: 98609776
Trademark Classes
Owner Contact Info
Else-Kroener-Str. 1
Bad Homburg 61352 , DE
Entity Type: 16
Legal Representation
Correspondence Address
Scott D. Woldow Smith, Gambrell & Russell, LLP
1055 Thomas Jefferson St. NW
Suite 400
Washington, DC 20007
United States
Trademark Details
Filing Date
June 20, 2024
Registration Date
Not Registered
Published for Opposition
February 4, 2025
Goods & Services
Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Pharmaceutical preparations for the treatment of autoimmune diseases, illnesses and conditions; Pharmaceutical preparations, namely, immunosuppressants; Pharmaceutical preparations for the treatment of plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and active enthesitis related arthritis, Crohn's disease, ulcerative colitis, hidradenitis colitis, hidradenitis suppurativa and non-infectious uveitis; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Biologics, namely, biological preparations for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Biologics, namely, biological preparations for the treatment of ankylosing spondylitis; Biological preparations for the treatment of and reducing signs and symptoms in adult patients with active ankylosing spondylitis; Protein therapeutics, namely, protein supplements; Pharmaceutical preparations for treating ankylosing spondylitis; Pharmaceutical preparations for the treatment of and for reducing signs and symptoms in adult patients with active ankylosing spondylitis